[en] For several years, near-infrared spectroscopy (NIRS) has become an analytical technique of great interest for the pharmaceutical industry, particularly for the non-destructive analysis of dosage forms. The goal of this study is to show the capacity of this new technique to assay the active ingredient in low-dosage tablets. NIR spectroscopy is a rapid, non-destructive technique and does not need any sample preparation. As an example, a binary mixture of microcrystalline cellulose and riboflavin was used to prepare tablets of different weights by direct compression. A prediction model was built by using a partial least square regression fit method. The NIR assay was performed by transmission. The results obtained by NIR spectroscopy were compared with a conventional UV-vis spectrophotometry method. The study showed that tablets can be individually analysed by NIR with high accuracy. It was shown that the variability of this new technique is less important than that of the conventional method which is the UV-vis spectrophotometry. (c) 2006 Elsevier B.V. All rights reserved.
Disciplines :
Pharmacy, pharmacology & toxicology Chemistry
Author, co-author :
Bodson, Cédric
Dewé, Walthère ; Université de Liège - ULiège > Analyse des médicaments
PAT-A Framework for Innovative Pharmaceutical Manufacturing and Quality Assurance, FDA, 2004 (http://fda.gov/cder).
Ciurczak E.W., and Drennen J.K. Practical Spectroscopy Series: Pharmaceutical and Medical Applications of Near-Infrared Spectroscopy vol. 31 (2002), M. Dekker, New York 192 pp
Plugge W., and Van der Vlies C. J. Pharm. Biomed. Anal. 10 (1992) 797-803
Gerhäusser C.I., and Kovar K.A. Appl. Spectrosc. 51 (1997) 1504-1510
Vredenbregt M.J., Caspers P.W.J., Hoogerbrugge R., and Barends D.M. Eur. J. Pharm. Biopharm. 56 (2003) 489-499
Ritchie G.E., Mark H., and Ciurczak E.W. AAPS Pharm. Sci. Tech. 4 (2003) 1-10 (Article 24)
Hubert Ph., Chiap P., Crommen J., Boulanger B., Chapuzet E., Mercier N., Bervoas-Martin S., Chevalier P., Grandjean D., Lagorce Ph., Laparra M.C., Laurentie M., and Nivet J.C. Anal. Chim. Acta 391 (1999) 135-148
Hubert Ph., Nguyen-Huu J.J., Boulanger B., Chapuzet E., Chiap P., Cohen N., Compagnon P.-A., Dewé W., Feinberg M., Lallier M., Laurentie M., Mercier N., Muzard G., Nivet C., and Valat L. J. Pharm. Biomed. Anal. 36 (2004) 579-586
Eustaquio A., Graham P., Jee R.D., Moffat A.C., and Trafford A.D. Analyst 123 (1998) 2303-2306
Boulanger B., Dewe W., Chiap P., Crommen J., and Hubert Ph. J. Pharm. Biomed. Anal. 32 (2003) 753-765
Marini R.D., Chiap P., Boulanger B., Rudaz S., Rozet E., Crommen J., and Hubert Ph. Talanta 68 (2006) 1166-1175